Plasmablastic lymphoma in Malawi

Abstract Plasmablastic lymphoma (PBL) clinical descriptions are scarce from sub-Saharan Africa (SSA) where both HIV and EBV are highly endemic. We identified 12 patients with pathologically confirmed PBL from a prospective cohort in Lilongwe, Malawi. Median age was 46 (range 26–71), seven (58%) were...

Full description

Bibliographic Details
Main Authors: Takondwa Zuze, Matthew S. Painschab, Ryan Seguin, Evarista Kudowa, Bongani Kaimila, Edwards Kasonkanji, Tamiwe Tomoka, Bal Mukunda Dhungel, Maurice Mulenga, Maria Chikasema, Blessings Tewete, Asekanadziwa Ntangwanika, Sarah Chiyoyola, Fred Chimzimu, Coxcilly Kampani, Robert Krysiak, Nathan D. Montgomery, Yuri Fedoriw, Satish Gopal
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Infectious Agents and Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13027-018-0195-4
_version_ 1819082900882063360
author Takondwa Zuze
Matthew S. Painschab
Ryan Seguin
Evarista Kudowa
Bongani Kaimila
Edwards Kasonkanji
Tamiwe Tomoka
Bal Mukunda Dhungel
Maurice Mulenga
Maria Chikasema
Blessings Tewete
Asekanadziwa Ntangwanika
Sarah Chiyoyola
Fred Chimzimu
Coxcilly Kampani
Robert Krysiak
Nathan D. Montgomery
Yuri Fedoriw
Satish Gopal
author_facet Takondwa Zuze
Matthew S. Painschab
Ryan Seguin
Evarista Kudowa
Bongani Kaimila
Edwards Kasonkanji
Tamiwe Tomoka
Bal Mukunda Dhungel
Maurice Mulenga
Maria Chikasema
Blessings Tewete
Asekanadziwa Ntangwanika
Sarah Chiyoyola
Fred Chimzimu
Coxcilly Kampani
Robert Krysiak
Nathan D. Montgomery
Yuri Fedoriw
Satish Gopal
author_sort Takondwa Zuze
collection DOAJ
description Abstract Plasmablastic lymphoma (PBL) clinical descriptions are scarce from sub-Saharan Africa (SSA) where both HIV and EBV are highly endemic. We identified 12 patients with pathologically confirmed PBL from a prospective cohort in Lilongwe, Malawi. Median age was 46 (range 26–71), seven (58%) were male, and six (50%) were HIV-positive. Eight patients were treated with CHOP and four with a modified EPOCH regimen. One-year overall survival was 56% (95% CI 24–79%), without clear differences based on HIV status. PBL occurs in Malawi in HIV-positive and HIV-negative individuals and can be treated successfully with curative intent, even in a low-resource setting in SSA.
first_indexed 2024-12-21T20:24:01Z
format Article
id doaj.art-3f82c56fb85e494a85160f3e0804d2fc
institution Directory Open Access Journal
issn 1750-9378
language English
last_indexed 2024-12-21T20:24:01Z
publishDate 2018-06-01
publisher BMC
record_format Article
series Infectious Agents and Cancer
spelling doaj.art-3f82c56fb85e494a85160f3e0804d2fc2022-12-21T18:51:25ZengBMCInfectious Agents and Cancer1750-93782018-06-011311410.1186/s13027-018-0195-4Plasmablastic lymphoma in MalawiTakondwa Zuze0Matthew S. Painschab1Ryan Seguin2Evarista Kudowa3Bongani Kaimila4Edwards Kasonkanji5Tamiwe Tomoka6Bal Mukunda Dhungel7Maurice Mulenga8Maria Chikasema9Blessings Tewete10Asekanadziwa Ntangwanika11Sarah Chiyoyola12Fred Chimzimu13Coxcilly Kampani14Robert Krysiak15Nathan D. Montgomery16Yuri Fedoriw17Satish Gopal18UNC Project-MalawiUNC Project-MalawiUNC Project-MalawiUNC Project-MalawiUNC Project-MalawiUNC Project-MalawiUNC Project-MalawiUNC Project-MalawiKamuzu Central HospitalUNC Project-MalawiUNC Project-MalawiUNC Project-MalawiUNC Project-MalawiUNC Project-MalawiUNC Project-MalawiUNC Project-MalawiUniversity of North CarolinaUniversity of North CarolinaUNC Project-MalawiAbstract Plasmablastic lymphoma (PBL) clinical descriptions are scarce from sub-Saharan Africa (SSA) where both HIV and EBV are highly endemic. We identified 12 patients with pathologically confirmed PBL from a prospective cohort in Lilongwe, Malawi. Median age was 46 (range 26–71), seven (58%) were male, and six (50%) were HIV-positive. Eight patients were treated with CHOP and four with a modified EPOCH regimen. One-year overall survival was 56% (95% CI 24–79%), without clear differences based on HIV status. PBL occurs in Malawi in HIV-positive and HIV-negative individuals and can be treated successfully with curative intent, even in a low-resource setting in SSA.http://link.springer.com/article/10.1186/s13027-018-0195-4Plasmablastic lymphomaHIVEBVEPOCHSub-Saharan Africa
spellingShingle Takondwa Zuze
Matthew S. Painschab
Ryan Seguin
Evarista Kudowa
Bongani Kaimila
Edwards Kasonkanji
Tamiwe Tomoka
Bal Mukunda Dhungel
Maurice Mulenga
Maria Chikasema
Blessings Tewete
Asekanadziwa Ntangwanika
Sarah Chiyoyola
Fred Chimzimu
Coxcilly Kampani
Robert Krysiak
Nathan D. Montgomery
Yuri Fedoriw
Satish Gopal
Plasmablastic lymphoma in Malawi
Infectious Agents and Cancer
Plasmablastic lymphoma
HIV
EBV
EPOCH
Sub-Saharan Africa
title Plasmablastic lymphoma in Malawi
title_full Plasmablastic lymphoma in Malawi
title_fullStr Plasmablastic lymphoma in Malawi
title_full_unstemmed Plasmablastic lymphoma in Malawi
title_short Plasmablastic lymphoma in Malawi
title_sort plasmablastic lymphoma in malawi
topic Plasmablastic lymphoma
HIV
EBV
EPOCH
Sub-Saharan Africa
url http://link.springer.com/article/10.1186/s13027-018-0195-4
work_keys_str_mv AT takondwazuze plasmablasticlymphomainmalawi
AT matthewspainschab plasmablasticlymphomainmalawi
AT ryanseguin plasmablasticlymphomainmalawi
AT evaristakudowa plasmablasticlymphomainmalawi
AT bonganikaimila plasmablasticlymphomainmalawi
AT edwardskasonkanji plasmablasticlymphomainmalawi
AT tamiwetomoka plasmablasticlymphomainmalawi
AT balmukundadhungel plasmablasticlymphomainmalawi
AT mauricemulenga plasmablasticlymphomainmalawi
AT mariachikasema plasmablasticlymphomainmalawi
AT blessingstewete plasmablasticlymphomainmalawi
AT asekanadziwantangwanika plasmablasticlymphomainmalawi
AT sarahchiyoyola plasmablasticlymphomainmalawi
AT fredchimzimu plasmablasticlymphomainmalawi
AT coxcillykampani plasmablasticlymphomainmalawi
AT robertkrysiak plasmablasticlymphomainmalawi
AT nathandmontgomery plasmablasticlymphomainmalawi
AT yurifedoriw plasmablasticlymphomainmalawi
AT satishgopal plasmablasticlymphomainmalawi